Table 3 Antibiotic resistance and susceptibility of the potential donor and recipient strains from disc diffusion test
Bacteria | Indication | AK 30 μg | CN 30 μg | TOB 10 μg | ENR 5 μg | MAR 50 μg | F 300 μg | C 30 μg | CT 25 μg | PB300 IE | RD 30 μg | SXT 25 μg | CTX30 μg | CEFT 30 μg | CL 30 μg | CPD 10 μg | CTX 5 μg | IPM 10 μg | MEM 10 μg | CIP 5 μg | FOS 50 μg | TGC 15 μg |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Escherichia coli | IMT 20751/402 | S | S | (R) | R | R | S | R | S | S | S | R | S | S | R | R | x | S | S | S | S | S |
Escherichia coli APEC | IMT11716 | S | S | S | S | S | S | R | S | S | S | S | S | S | S | S | x | S | S | S | S | S |
S. enterica serovar Typhimurium | L1219-R32 | S | S | S | S | S | S | S | S | S | S | R | S | S | S | S | x | S | S | S | S | S |
Serratia marcescens subsp. marcescens | DSM 30122 | S | S | S | S | S | S | S | R | R | S | S | S | S | R | S | x | S | S | S | S | S |
ESBL Escherichia coli (CTX-M-1) | ESBL 10682 | S | S | S | S | S | S | S | S | S | S | S | S | ? | R | R | x | x | x | x | x | x |
ESBL Escherichia coli (TEM-52) | ESBL 10689 | S | S | S | S | S | S | S | S | S | S | R | S | S | S | R | x | x | x | x | x | x |
ESBL Escherichia coli (SHV-12) | ESBL 10708 | S | S | S | S | S | S | (R) | S | S | S | S | S | S | R | R | x | x | x | x | x | x |
Enterobacter cloacae | DSM 30060 | S | S | S | S | S | (R) | S | S | S | S | S | x | x | x | x | S | S | S | S | S | S |
ESBL Escherichia coli (CTX-M-15) | ESBL 10716 | S | R | R | R | R | S | R | S | S | x | R | R | R | R | R | R | S | S | R | S | S |
ESBL Escherichia coli (CMY-2, TEM-1) | ESBL 10717 | S | S | S | S | S | I | S | R | R | x | S | R | R | R | R | R | S | S | S | S | S |